Skip to main content
SpringerLink
Log in

Therapie der „missed abortion“ – wo stehen wir?

Management of missed abortion—Where do we stand?

  • In der Diskussion
  • Published:
Gynäkologische Endokrinologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rai R, Regan L (2006) Recurrent miscarriage. Lancet 368:601–611. https://doi.org/10.1016/S0140-6736(06)69204-0

    Article  Google Scholar 

  2. van Dijk MM, Kolte AM, Limpens J et al (2020) Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update 26:356–367. https://doi.org/10.1093/humupd/dmz048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. The ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB et al (2018) ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018:1337–1313. https://doi.org/10.1093/hropen/hoy004

    Article  Google Scholar 

  4. Nielsen S, Hahlin M (1994) Expectant management of first-trimester sponteous abortion. Lancet 345:84–86

    Article  Google Scholar 

  5. Wu H‑L, Marwah S, Wang P et al (2017) Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Sci Rep. https://doi.org/10.1038/s41598-017-01892-0

    Article  PubMed  PubMed Central  Google Scholar 

  6. Jurkovic D, Ross JA, Nicolaides KH (1998) Expectant management of missed miscarriage. Br J Obstet Gynaecol 105:670–671. https://doi.org/10.1111/j.1471-0528.1998.tb10184.x

    Article  CAS  PubMed  Google Scholar 

  7. Sliwa J, Kryza-Ottou A, Rosner-Tenerowicz A et al (2019) Comparison of the diagnostic value of histopathological examinations of miscarriage products after pharmacological induction of miscarriage and curettage. Ginekol Pol 90:331–335. https://doi.org/10.5603/GP.2019.0061

    Article  PubMed  Google Scholar 

  8. Vyas NA, Vink JS, Ghidini A et al (2006) Risk factors for cervical insufficiency after term delivery. Am J Obstet Gynecol 195:787–791. https://doi.org/10.1016/j.ajog.2006.06.069

    Article  PubMed  Google Scholar 

  9. McCarthy FP, Khashan AS, North RA et al (2013) Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth. Hum Reprod 28:3197–3206. https://doi.org/10.1093/humrep/det332

    Article  PubMed  Google Scholar 

  10. Hooker AB, Lemmers M, Thurkow AL et al (2014) Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 20:262–278. https://doi.org/10.1093/humupd/dmt045

    Article  CAS  Google Scholar 

  11. Hooker AB, de Leeuw RA, van de Ven PM et al (2018) Reproductive performance after the application of hyaluronic acid gel after dilation and curettage in women who have experienced at least one previous curettage: long-term results of a multicenter prospective randomized trial. Fertil Steril 110:1231–1238. https://doi.org/10.1016/j.fertnstert.2018.07.021

    Article  CAS  PubMed  Google Scholar 

  12. Hooker AB, de Leeuw R, van de Ven PM et al (2017) Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial. Fertil Steril 107:1223–1231.e3. https://doi.org/10.1016/j.fertnstert.2017.02.113

    Article  CAS  PubMed  Google Scholar 

  13. Berg J, Hamel CC, Snijders MP et al (2019) Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial). 19(1):443. https://doi.org/10.1186/s12884-019-2497-y

    Article  CAS  Google Scholar 

  14. WHO (Hrsg) (2018) Medical management of abortion. World Health Organization, Geneva (Licence: CC BY-NC-SA 3.0 IGO.)

    Google Scholar 

  15. Gemzell-Danielsson K, Ho PC, Gómez Ponce de León R et al (2007) Misoprostol to treat missed abortion in the first trimester. Int J Gynaecol Obstet 99:S182–S185. https://doi.org/10.1016/j.ijgo.2007.09.008

    Article  CAS  PubMed  Google Scholar 

  16. Tang OS, Schweer H, Seyberth HW et al (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17:332–336. https://doi.org/10.1093/humrep/17.2.332

    Article  CAS  PubMed  Google Scholar 

  17. National Guideline Alliance (UK) (2019) Ectopic pregnancy and miscarriage: diagnosis and initial management. National Institute for Health and Care Excellence, London ((NICE Guideline, No. 126.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK544906/)

    Google Scholar 

  18. Colleselli V, Nell T, Bartosik T et al (2016) Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study. Arch Gynecol Obstet 294:1265–1272. https://doi.org/10.1007/s00404-016-4179-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Schreiber CA, Creinin MD, Atrio J et al (2018) Mifepristone pretreatment for the medical management of early pregnancy loss. N Engl J Med 378:2161–2170. https://doi.org/10.1056/NEJMoa1715726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Colleselli V, Schreiber CA, D’Costa E et al (2013) Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice. Arch Gynecol Obstet 289:1341–1345. https://doi.org/10.1007/s00404-013-3105-4

    Article  PubMed  Google Scholar 

  21. (2020) Abstracts 36th Virtual Annual Meeting of the European Society of Human Reproduction and Embryology. Human Reproduction 1–522. https://doi.org/10.1093/humrep/35.Supplement_1.1

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Deutschland

    Alexander Freis

Authors
  1. Alexander Freis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Freis.

Ethics declarations

Interessenkonflikt

A. Freis gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

H. Kentenich, Berlin

W. Küpker, Baden-Baden

S. Tschudin, Basel

L. Wildt, Innsbruck

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Freis, A. Therapie der „missed abortion“ – wo stehen wir?. Gynäkologische Endokrinologie 19, 73–75 (2021). https://doi.org/10.1007/s10304-020-00354-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-020-00354-7

Search

Navigation